Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer

BACKGROUND: Monitoring circulating tumor cells (CTC) has been shown to be prognostic in most solid malignancies. There is no CTC assay in clinical use for lung cancer therapy monitoring due to inconclusive clinical utility data. Limited data has been published outside of the standard CTC enumeration...

Descripción completa

Detalles Bibliográficos
Autores principales: Shishido, Stephanie N., Carlsson, Anders, Nieva, Jorge, Bethel, Kelly, Hicks, James B., Bazhenova, Lyudmila, Kuhn, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714097/
https://www.ncbi.nlm.nih.gov/pubmed/31462312
http://dx.doi.org/10.1186/s12967-019-2035-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714097/
https://www.ncbi.nlm.nih.gov/pubmed/31462312
http://dx.doi.org/10.1186/s12967-019-2035-8

Ejemplares similares